Katriona M. Brooksbank

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Real-world impact of implementing a point-of-care high-sensitivity troponin pathway on emergency department flow.

Real-world impact of implementing a point-of-care high-sensitivity troponin pathway on emergency department flow.

Journal: Scottish medical journal

Published: September 04, 2026

Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF).

Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF).

Journal: Journal of the American College of Cardiology

Published: April 14, 2026

Cardiac myosin-binding protein C in community-based patients with suspected heart failure.

Cardiac myosin-binding protein C in community-based patients with suspected heart failure.

Journal: European journal of heart failure

Published: December 16, 2025

Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.

Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.

Journal: JACC. CardioOncology

Published: April 09, 2025

Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure.

Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure.

Journal: European journal of heart failure

Published: April 08, 2025

Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging.

Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging.

Journal: Heart (British Cardiac Society)

Published: December 07, 2024

A digital diagnostic pathway for heart failure: an economic evaluation.

A digital diagnostic pathway for heart failure: an economic evaluation.

Journal: Cost effectiveness and resource allocation : C/E

Published: November 05, 2024

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).

Journal: European journal of heart failure

Published: September 27, 2024

UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide.

UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 30, 2024

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design.

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design.

Journal: ESC heart failure

Published: March 21, 2024

Early detection of heart failure using in-patient longitudinal electronic health records.

Early detection of heart failure using in-patient longitudinal electronic health records.

Journal: PloS one

Published: January 17, 2024

A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.

A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: July 22, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026